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Survival Factor-Mediated BAD Phosphorylation
Raises the Mitochondrial Threshold for Apoptosis
including the PI3K/Akt, Ras/MAPK/Rsk, and PKA path-
ways (Datta et al., 1999; Talapatra and Thompson, 2001).
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The proapoptotic BCL-2 family member BAD has beenGrowth factor suppression of apoptosis correlates
suggested to link survival signals to the mitochondrialwith the phosphorylation and inactivation of multiple
cell death machinery (Zha et al., 1996). BAD belongs toproapoptotic proteins, including the BCL-2 family
a subfamily of BCL-2 proteins that are similar to BCL-2member BAD. However, the physiological events re-
in that they share a BCL-2 homology 3 (BH3) domain.quired for growth factors to block cell death are not
These “BH3-only” proteins serve as molecular sentinelswell characterized. To assess the contribution of BAD
whose activity or expression is regulated in response toinactivation to cell survival, we generated mice with
specific death stimuli (Puthalakath and Strasser, 2002).point mutations in the BAD gene that abolish BAD
BAD is a BH3-only protein whose activity is regulatedphosphorylation at specific sites. We show that BAD
by extracellular survival signals. Growth factors inducephosphorylation protects cells from the deleterious
the phosphorylation of BAD at three sites, Ser-112, Ser-effects of apoptotic stimuli and attenuates death path-
136, and Ser-155, which inactivates the proapoptoticway signaling by raising the threshold at which mito-
activity of BAD (Datta et al., 2000; Lizcano et al., 2000;chondria release cytochrome c to induce cell death.
Virdee et al., 2000; Zha et al., 1996). Several kinases thatThese findings establish a function for endogenous
have been implicated in survival signaling have beenBAD phosphorylation, and elucidate a mechanism by
proposed to mediate BAD phosphorylation, includingwhich survival kinases block apoptosis in vivo.
Akt, Rsk, PAK, p70S6K, and PKA (Bonni et al., 1999; Datta
et al., 1999; Harada et al., 2001; Schurmann et al., 2000;Introduction
Tan et al., 1999). Upon growth factor withdrawal, BAD
is dephosphorylated at Ser-112, Ser-136, and Ser-155,Growth factors play critical roles in promoting the sur-
and this active form of BAD binds to prosurvival BCL-2
vival of many different cell populations during metazoan
family members at the mitochondria. The binding of BAD
development (Raff, 1992). As the nervous system devel-
to prosurvival BCL-2 proteins is followed by the oligo-
ops, neurons compete for limiting quantities of neuro- merization of the proapoptotic BCL-2 proteins BAX and
trophic factors that promote the survival of those neu- BAK, which results in mitochondrial dysfunction, cyto-
rons that successfully innervate their targets (Segal and chrome c release, caspase activation, and apoptotic
Greenberg, 1996). Likewise, cells of the immune system death (Cheng et al., 2001; Wei et al., 2001; Zong et al.,
secrete cytokines whose activity induces the survival of 2001).
populations of lymphocytes that are essential to normal The phosphorylation of endogenous BAD at Ser-112,
immune function (Plas et al., 2002). Growth factors also Ser-136, and Ser-155 occurs under many conditions in
function in mature organisms to promote the survival of which growth factors promote cell survival in cell culture
cells challenged with apoptotic stimuli such as tumor (reviewed in Datta et al., 1999). This correlation has led
necrosis factor  (TNF) or ionizing radiation (Rosen et to the suggestion that BAD phosphorylation is essential
al., 1999; Venters et al., 2000). for survival factors to block apoptosis. Consistent with
The importance of growth factors in attenuating cell a role for BAD inactivation in survival signaling, overex-
death has focused recent efforts on identifying the intra- pressed BAD induces cell death that can be blocked by
cellular signaling pathways that transduce survival sig- survival kinases. However, it remains to be determined
nals. A number of growth factor-regulated protein kinase whether growth factors require the phosphorylation and
cascades have been implicated in survival signaling, inactivation of BAD to promote cell survival when BAD
is expressed in its normal physiological contexts.
To address the physiological importance of BAD3 Correspondence: michael.greenberg@tch.harvard.edu
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phosphorylation in trophic factor-mediated cell survival, BAD/ and BAD3SA/3SA tissues were similar. In contrast,
Western blotting of whole-brain lysate with an antibodywe generated mutant mice (BAD3SA/3SA) in which the three
regulatory serines in BAD (Ser-112, Ser-136, and Ser- that specifically recognizes BAD when it is phosphory-
lated at Ser-155 detected Ser-155-phosphorylated BAD155) were converted to alanines, rendering endogenous
BAD refractory to phosphorylation. We reasoned that in wild-type tissue, but failed to detect phosphorylated
BAD in tissue obtained from BAD3SA/3SA mice (Figure 1D).any specific defects observed in BAD3SA/3SA mutant mice
would reveal the circumstances in which BAD inactiva- Similar results were obtained using antibodies that spe-
cifically recognize BAD when it is phosphorylated attion by phosphorylation is required for normal cell func-
tion. We show here that in select cell types, survival Ser-112 or Ser-136 (data not shown), indicating that we
had generated animals in which endogenous BAD is nofactors require BAD phosphorylation to prevent devel-
opmental apoptosis, as growth factor-dependent sur- longer capable of being phosphorylated at the three
critical regulatory sites (Ser-112, Ser-136, and Ser-155),vival is attenuated in BAD3SA/3SA cells from the immune
and nervous systems. These findings demonstrate that but in which BAD levels and patterns of expression are
normal.BAD dephosphorylation alone, even when survival fac-
tors are present, is sufficient to promote cell death in To establish that mutation of the regulatory serines
in BAD did not create a BAD molecule that functions insome circumstances.
The analysis of BAD3SA/3SA mice also reveals that a a dominant manner to interfere with survival-promoting
kinases, we assessed the expression levels and phos-primary function of BAD phosphorylation is to allow
growth factors to block cell death induced by a variety phorylation status of Akt, PAK, and p90Rsk, three kinases
proposed to mediate BAD phosphorylation. As shownof apoptotic stimuli. Growth factors can block cell death
induced by either the cell-extrinsic apoptotic pathway in Figure 1E, the expression levels and phosphorylation
status of these kinases was similar in BAD/ and(which is activated by death cytokines such as TNF),
or by the cell-intrinsic apoptotic pathway (which is acti- BAD3SA/3SA brain lysates, as were the levels and phos-
phorylation status of other survival signaling substrates,vated after cellular damage). Activation of either path-
way results in increased activity of proapoptotic BCL-2 including FOXO3a and CREB (Figure 1F; Datta et al.,
1999). In addition, the levels of expression of BCL-2family members, which induce mitochondrial dysfunc-
tion to cause cell death. We find that growth factors family members were also not significantly altered in the
BAD3SA/3SA animals (Figure 1G). These data demonstraterequire endogenous BAD phosphorylation to protect
cells from death induced by activation of cell-intrinsic that the serine-to-alanine mutations in endogenous BAD
render BAD unresponsive to survival signals, but do notor cell-extrinsic death pathways because BAD phos-
phorylation raises the threshold at which mitochondria apparently alter the signaling pathways that regulate
cell survival upstream of BAD or the expression levelsrelease cytochrome c. Taken together, these findings
identify a biological function for growth factor-mediated of other BCL-2 family members.
BAD phosphorylation in regulating cellular responses to
death signals.
A Requirement for BAD Phosphorylation during
Immune System DevelopmentResults
Homozygous BAD3SA/3SA mice were obtained at the nor-
mal Mendelian frequency, and histological analysis ofGeneration of BAD Knockin Mice
most tissues from BAD3SA/3SA animals revealed no grossTo generate BAD knockin mice (BAD3SA/3SA) in which each
abnormalities. However, examination of immune tissuesof the regulatory serines (Ser-112, Ser-136, and Ser-155)
revealed that mutant BAD animals exhibit a defect inwas converted to alanine, we constructed a targeting
the growth factor-dependent survival of lymphocytes.vector in which mutations in these three serines were
Both the weight of the thymus (37.5  1.3 mg versusintroduced into the genomic BAD sequence and linked
22  1.0 mg, p  0.0007) and the number of cells in theto silent restriction fragment length polymorphisms
thymus (6.4  107  0.7 cells versus 3.5  107  0.1(RFLPs) to facilitate genotyping (Figure 1A). This tar-
cells, p 0.01) were significantly lower in BAD3SA/3SA thangeting vector, which contained a positive selection
in BAD/ adult mice (Figure 2A). Therefore, we soughtmarker flanked by recognition sites for the FlpE recombi-
to determine whether BAD phosphorylation was re-nase (FRT-Neo-FRT) successfully recombined with the
quired for the appropriate development of T cells. In theendogenous BAD locus of embryonic stem (ES) cells, as
thymus, T cell development progresses in a stepwiserevealed by Southern blotting (Figure 1B). After germline
manner, each stage of which is characterized by thetransmission of the mutant BAD allele in mice was estab-
expression of a unique complement of cell surface mark-lished, the FRT-Neo-FRT cassette was excised from
ers (Shortman and Wu, 1996). An early T cell progenitorthe genomic BAD sequence by crossing BAD3SA(NEO)/
in the thymus, the pre-pro-T cell, expresses the CD44animals with transgenic mice that express the FlpE re-
marker but does not express either the CD25 marker orcombinase (Farley et al., 2000). Excision of the neomycin
the T cell receptor. As pre-pro-T cells differentiate intogene was confirmed by Southern blotting to detect the
pro-T cells, they express CD25 and undergo T cell recep-presence or absence of the FRT-Neo-FRT cassette, and
tor rearrangement. As pro-T cells differentiate into pre-Ta PCR-based assay was performed to detect the RFLPs
cells, they express the T cell receptor, and as maturationlinked to the BAD serine-to-alanine mutations (Figure 1C).
continues, they express the CD4 and/or CD8 coreceptorWestern blot analysis of protein extracts of whole
molecules. To analyze thymic development in BAD/brain (Figure 1D) and other organs (data not shown)
revealed that the amounts of BAD protein expressed in and BAD3SA/3SA mice, the numbers of thymocytes at each
Defective Survival Signaling in BAD Knockin Mouse
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Figure 1. Generation and Characterization of
BAD3SA/3SA Mice
(A) Targeting strategy to generate BAD3SA/3SA
mice. Map of the BAD locus indicates restric-
tion markers (X, XbaI; B, BamHI; EV, EcoRV;
S, SmaI; E, EcoRI) and exons (open boxes).
Serine-to-alanine mutations were linked to
RFLPs as indicated, and a PGK-NEO cassette
with flanked FRT sites (triangles) was inserted
into the targeting vector downstream of the
BAD 3 UTR. After generation of BAD3SA(NEO)/
animals (see below), animals were crossed to
FlpE transgenic animals to excise the Neo
cassette.
(B) Southern blots indicating appropriate
gene targeting as assessed using the probe
indicated in (A). The left panel shows increased
fragment length due to FRT-Neo-FRT cas-
sette insertion into the BamHI fragment,
whereas the right panel shows decreased
length of the EcoRI fragment due to success-
ful introduction of an EcoRI RFLP into BAD
exon 3.
(C) Analysis of excision of the FRT-Neo-FRT
cassette. Animals depicted are progeny of a
BAD3SA(NEO)/ male crossed to a FlpE trans-
genic female. The lower panel is an EtBr-
stained agarose gel of PCR for the FlpE
transgene. The middle panel is a similar gel of
a PCR fragment for the RFLP mutation marker
after digestion with SmaI, demonstrating that
both animals have a single copy of the
BAD3SA/3SA mutant allele. The top panel is a
Southern blot with the probe indicated in (A),
demonstrating that the FRT-Neo-FRT cas-
sette has successfully been excised in animal
#215.
(D) Western blots of SDS lysates of whole
brain, probed with either C-20 anti-BAD
(-BAD), or anti-p155BAD (-pBAD). BADL is
full-length mouse BAD, and BADS is an iso-
form of BAD missing the BAD N terminus.
BADS is the predominant form of BAD in most
tissues (S.R.D. and M.E.G., unpublished
data). The band above the BADL band is non-
specific. The shift in BADS mobility in the up-
per panel observed in the BAD/ and BAD/
3SA lanes is indicative of phosphorylation, and
the increased apparent intensity of the BADS
band in the mutant animals reflects the col-
lapse of this shift (Zha et al., 1996).
(E–G) Western blots of SDS lysates of whole
brain, probed with the antibodies indicated.
Two-dimensional gel electrophoresis of simi-
lar lysates from BAD/ and BAD3SA/3SA brains
followed by Western blotting with a phospho-
Akt substrate antibody (CST) were also per-
formed, and no differences between the wild-
type and mutant animals was detected (data
not shown).
Developmental Cell
634
Figure 2. Pro-T and -B Cell Survival Defects in the BAD3SA/3SA Mouse
(A) Weight (left) and cell number (right) of thymuses isolated from 3-month-old animals (n  6).
(B) Representative FACS analysis of CD25/CD3CD4CD8 pro-T cells (left), and CD4/CD8 ratios (right) of 3-month-old littermate animals.
No significant differences in the CD4/CD8 ratios were observed when BAD3SA/3SA and BAD/ mice were compared.
(C) Western blot of thymocytes isolated from RAG2/ animals. Thymuses from 3-week-old RAG2/ animals were dissociated and the resultant
thymocytes were cultured in either no survival factors or in 10 ng/ml IL-7 for 6 hr. More than 95% of viable cells from RAG2/ thymuses were
CD25CD3CD4CD8 as assessed by FACS analysis (data not shown). Whole-cell lysates were resolved by SDS-PAGE and subjected to
Western blot analysis with the antibodies indicated.
(D) Survival of sorted CD25CD3CD4CD8 pro-T cells from BAD/ and BAD3SA/3SA mice after 24 hr culture in either no survival factors
or 10 ng/ml IL-7. Survival was assessed by trypan blue exclusion.
(E) FACS sorting for B220CD43CD19 pre-pro-B cells and B220CD43CD19 pro-B cells (upper panel). Data shown are representative
of differences observed in four pairs of 3-month-old wild-type and mutant animals. The lower left panel depicts the number of IL-7-dependent
methylcellulose pre-B colonies recovered from bone marrow of indicated mice after 1 week of culture in a methylcellulose matrix (n  3). The
lower right panels depict numbers of B220 B cells in bone marrow and spleen as assessed by FACS sorting (n  5).
Defective Survival Signaling in BAD Knockin Mouse
635
stage of development were analyzed by fluorescence- the total number of mature splenic B cells were lower
activated cell sorting (FACS). These experiments re- in BAD3SA/3SA animals relative to their wild-type counter-
vealed that BAD3SA/3SA mice, when compared to wild- parts (Figure 2E). These findings demonstrate that BAD
type animals, have significantly fewer CD25pro-T cells phosphorylation is important for the normal develop-
(50.6  9.1 percent of wild-type; Figure 2B). Consistent ment of pro-B and pro-T cells, and are consistent with
with this finding, the proportion of CD44CD25 pre- a model in which IL-7-mediated BAD phosphorylation
pro-T cells was increased in BAD3SA/3SA thymuses is important for the ability of IL-7 to promote cell survival.
(180.9  27.5 percent of BAD/). However, no signifi-
cant difference in the absolute number of pre-pro-T cells Growth Factor-Mediated BAD Phosphorylation
in BAD/ and BAD3SA/3SA thymuses was detected, indi- Is Required for Protection of Cells
cating that BAD3SA/3SA thymuses contain normal numbers from Multiple Apoptotic Stimuli
of pre-pro-T cells, but decreased numbers of pro-T cells. The observation that BAD mutant mice exhibit defects
BAD phosphorylation apparently does not regulate the in the growth factor-dependent survival of immune cells
development of cells generated after the pro-T stage, led us to investigate whether BAD phosphorylation plays
as the relative proportions of CD4 and CD8 cells, a more general role in cell survival. We assessed the
and the expression of the T cell receptor and markers ability of specific survival factors to block cell death in
of T cell activation, were normal in BAD3SA/3SA mice. Be- cultured cerebellar granule neurons (D’Mello et al., 1993;
cause pro-T cells give rise to the vast majority of the Dudek et al., 1997). In the absence of survival factors,
cells in the thymus, these results suggest that the low cultured cerebellar granule neurons from BAD/ and
thymic weight and cellularity observed in the BAD3SA/3SA BAD3SA/3SA mice underwent apoptosis to a similar extent
animals is due to a requirement for endogenous BAD (Figure 3A). This finding is not surprising, given that
phosphorylation in the development or survival of pro-T endogenous BAD is dephosphorylated in cerebellar
cells. granule neurons upon removal of survival stimuli (Datta
Since the cytokine interleukin-7 (IL-7) has been shown et al., 2000; Gleichmann et al., 2000). As growth factors,
to be required for the survival of prothymocytes in vivo including the insulin-like growth factor 1 (IGF-1), induce
(Peschon et al., 1994; von Freeden-Jeffry et al., 1995), endogenous BAD phosphorylation in wild-type neurons
we tested the possibility that the observed loss of pro-T but cannot stimulate BAD phosphorylation in BAD3SA/3SA
cells in BAD3SA/3SA mice was due to the inability of IL-7 neurons, we compared the ability of IGF-1 to promote
to promote the survival of these cells. To obtain an the cell survival of BAD/and BAD3SA/3SA cerebellar gran-
adequate number of cells to perform biochemical analy- ule cells. We found that after 48 hr of treatment with
sis, we isolated pro-T cells from 3-week-old RAG2/ IGF-1, significantly more wild-type neurons survived
animals, as thymocytes from these mice are develop- than BAD3SA/3SA neurons, indicating that BAD phosphory-
mentally arrested at the pro-T stage (Shinkai et al., 1992). lation contributes to the IGF-1-mediated survival of cer-
Consistent with the possibility that in pro-T cells IL-7 ebellar granule neurons (Figure 3A).
normally promotes survival by phosphorylating and in- Despite the defects observed in IGF-1-mediated sur-
activating BAD, we found by Western blot analysis that
vival in BAD3SA/3SA neurons, IGF-1 was still capable of
BAD was expressed in pro-T cells from RAG2/ mice,
partially blocking the apoptosis of BAD3SA/3SA cells, sug-
and became newly phosphorylated after treatment with
gesting that IGF-1 and other growth factors may also
IL-7 (Figure 2C). These findings led us to test whether
inhibit other proapoptotic proteins to block cell death.the loss of pro-T cells observed in the BAD3SA/3SA mutant
One such target may be FOXO3a, a transcription factormice reflects a failure of IL-7 to promote the survival of
of the Forkhead family, whose activity is regulated byBAD3SA/3SA pro-T cells. We isolated pro-T cells from
growth factor-dependent phosphorylation (Brunet etpooled BAD/ or BAD3SA/3SA thymuses by cell sorting,
al., 2001). In the presence of survival factors, FOXO3aand assessed the ability of IL-7 to promote the survival
is phosphorylated and localized to the cytoplasm,of these cells. As shown in Figure 2D, IL-7 potentiated
whereas in the absence of survival factors, FOXO3a isthe survival of cultured wild-type pro-T cells, but was
dephosphorylated and localized to the nucleus, whereless effective at promoting the survival of BAD3SA/3SA
it induces many genes including several that promotepro-T cells. These findings demonstrate that in wild-
cell death. Although implicated in the induction of celltype pro-T cells, IL-7 promotes survival in part by phos-
death, FOXO3a, when rendered constitutively active andphorylating and inactivating BAD.
overexpressed, only weakly induces apoptosis in neu-Pro-B cells also require IL-7 for their survival in vivo
rons (Brunet et al., 1999). This finding raises the possibil-(Peschon et al., 1994; von Freeden-Jeffry et al., 1995).
ity that under physiological conditions, FOXO3a mightAnalysis of cells of the B lineage revealed a specific
collaborate with other proapoptotic proteins to promotedefect in pro-B cells in BAD3SA/3SA mice. FACS analysis
cell death. If this were found to be true, survival factorsof B cell precursors revealed that the bone marrow of
might be expected to coordinately inactivate FOXO3aBAD3SA/3SA mice contained fewer pro-B cells than did the
and other proapoptotic proteins, such as BAD, to effec-bone marrow of wild-type mice (Figure 2E). Additional
tively block apoptosis. To test whether BAD dephos-defects were also detected at later stages of B cell
phorylation sensitizes cells to the proapoptotic activitydevelopment in BAD3SA/3SA mice, which may reflect the
of FOXO3a, cultured BAD/ or BAD3SA/3SA cerebellarlower numbers of pro-B cells in mutant animals. For
granule cells were transfected with constructs express-example, BAD3SA/3SA bone marrow produced fewer pre-B
ing a constitutively active mutant of FOXO3a, in whichcell colonies than did BAD/ bone marrow after in vitro
the phosphorylation sites normally induced by growthculture in methylcellulose-containing medium. In addi-
tion, the total number of B cells in the bone marrow and factors are mutated to alanines (FOXO3aTM; Figure 3B).
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These results also demonstrate that activation of a sec-
ond apoptotic pathway more effectively reveals the pro-
apoptotic function of dephosphorylated BAD.
The observation that BAD dephosphorylation sensi-
tizes cells to apoptosis induced by active FOXO3a led
us to investigate whether the functional synergy be-
tween BAD and FOXO3a is specific, or whether it reflects
a more general ability of dephosphorylated BAD to sen-
sitize cells to the activation of other apoptotic signaling
pathways. If this were found to be true, then endogenous
BAD phosphorylation would be essential for the normal
ability of growth factors to attenuate cell death caused
by proapoptotic signaling. To address this possibility,
we generated mouse embryo fibroblasts (MEF) from
E13.5 BAD/ and BAD3SA/3SA embryos. MEFs are well
suited for studying whether BAD phosphorylation blocks
death induced by death receptor activation or genotoxic
stress, since the phosphorylation state of BAD in MEFs
can be regulated by the addition or withdrawal of growth
factors (Figure 4A). In addition, BAD3SA/3SA MEFs appear
healthy and do not exhibit an increased rate of sponta-
neous apoptosis relative to BAD/ MEFs in the pres-
ence or absence of growth factors (data not shown).
To test the possibility that endogenous BAD phos-
phorylation in MEFs protects cells from the potentially
lethal effects of apoptotic stimuli, we challenged MEFs
with cell-extrinsic activators of death receptor signaling
(such as TNF or anti-Fas antibodies that ligate and
activate the Fas receptor) or DNA-damaging agents
(such as 	 irradiation or the chemotherapeutic agent
etoposide). We cultured both BAD/ and BAD3SA/3SA
MEFs in 15% fetal calf serum, IGF-1, or platelet-derived
growth factor (PDGF), conditions that induce BAD phos-
phorylation, treated the cells with either death receptor
ligands or DNA-damaging agents, and assessed the rel-
ative levels of cell death. As shown in Figures 4B and 4C,
BAD phosphorylation effectively countered cell deathFigure 3. Analysis of Cerebellar Granule Neurons from BAD3SA/3SA
induced by anti-Fas antibodies, TNF, 	 irradiation, andMice
etoposide in wild-type MEFs. Notably, growth factors(A) Cerebellar granule cells were isolated from P5 mouse pups,
that induce BAD phosphorylation and cell survival incultured for 5 days, and then either starved or treated with 50 ng/
ml IGF-1 for 48 hr. Cell survival was assessed in a blinded manner BAD/MEFs failed to block apoptosis induced by either
by neurite fragmentation and nuclear morphology after Hoechst death receptor activation or DNA-damaging agents in
33342 staining (n  3). BAD3SA/3SA MEFs (Figures 4B and 4C). Analysis of the
(B) Cerebellar granule neurons were isolated as in (A), cotransfected
responses of BAD/ and BAD3SA/3SA MEFs cultured inwith the indicated constructs and a 
-galactosidase transfection
survival factors to a range of doses of anti-Fas antibod-marker, and after 24 hr were switched into IGF-1. After a culture of
ies and TNF revealed that constitutive BAD dephos-cells in IGF-1 for 12 hr, cells were fixed and stained with an anti-
phorylation lowered the threshold at which activation of
-gal antibody, and positive transfectants were scored as in (A)
(n  3). the cell-extrinsic pathway of cell death induces apopto-
sis (Figure 4D). In contrast, as shown in Figures 4B and
4C, when cultured in the absence of survival factors,As previously demonstrated, FOXO3aTM only weakly
BAD/ and BAD3SA/3SA MEFs underwent equivalent lev-induced death in wild-type cerebellar granule neurons
els of cell death after treatment with anti-Fas antibodies,cultured in the presence of IGF-1, suggesting that IGF-1
TNF, 	 irradiation, or etoposide, as might be expected,suppresses cell death by inducing the phosphorylation
as BAD is dephosphorylated in the absence of survivalof additional target molecules. One such target molecule
factors in both wild-type and BAD3SA/3SA cells. These re-is likely BAD, as transfection of BAD3SA/3SA mutant neu-
sults demonstrate that endogenous BAD phosphoryla-rons with FOXO3aTM resulted in the robust induction
tion is required for survival factors to block death in-of cell death in the presence of IGF-1 (Figure 3B). This
duced by apoptotic signaling.effect required the ability of FOXO3aTM to bind to DNA,
Survival factors were able to block cell death inducedas mutation of the DNA binding domain of FOXO3aTM
by cell-extrinsic death stimuli in the absence of newabrogated the ability of FOXO3aTM to promote the
protein synthesis (Figures 4B and 4D), but were unabledeath of either wild-type or BAD3SA/3SA neurons. These
to block cell death in the absence of PI3K activity, asresults indicate that growth factors promote survival by
treatment of MEFs with LY294002, a chemical inhibitorinducing the phosphorylation and inactivation of multi-
ple proapoptotic molecules, such as BAD and FOXO3a. of PI3K, blocked the antiapoptotic activity of survival
Defective Survival Signaling in BAD Knockin Mouse
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Figure 4. Survival Factors Require BAD
Phosphorylation to Block Apoptosis Induced
by Cell-Extrinsic and Cell-Intrinsic Death
Pathways
(A) Western blots of wild-type MEF cell ly-
sates assessing BAD phosphorylation levels.
MEFs were plated, allowed to reach conflu-
ence, and deprived of survival factors. MEFs
were then stimulated as indicated, lysed in
RIPA buffer, and subjected to Western blot
analysis after SDS-PAGE with either the anti-
BAD c-20 antibody (-BAD) or the anti-
p112BAD antibody (-pBAD) as indicated.
(B) Time course of death induced in primary
MEFs cultured in serum after treatment with
either 200 ng/ml Jo2 anti-Fas antibody or 1
ng/ml TNF and 200 g/ml cyclohexamide
(n  3). Some cells were also cotreated with
30M LY294002 as indicated. Note that treat-
ment of cells with cyclohexamide alone did
not induce cell death, and that similar results
were obtained when cells were cultured in
IGF-1 or PDGF (data not shown). Similar data
have been obtained utilizing an indepen-
dently isolated pair of MEF lines.
(C) MEFs were cultured in the media indicated
and were treated with either 5 Gray 	 irradia-
tion or 400 M etoposide for 24 hr (n  3).
(D) Conditions in (D) are similar to (A) and (B),
except that MEFs were treated with doses of
anti-Fas antibodies or TNF and 200 g/ml
CHX as indicated, and death was assessed
at 8 hr posttreatment (n  3).
factors (Figure 4B). These findings suggest that growth BAD3SA/3SA Mice Show Increased Sensitivity
to Apoptotic Stimulifactors suppress the effectiveness of apoptotic signal-
ing at least in part through the PI3K-dependent post- We next considered whether growth factor-mediated
BAD phosphorylation also protects whole animals fromtranslational modification of proteins such as BAD.
Taken together, these results demonstrate that a func- death signals. We initially focused on the responses of
BAD/ and BAD3SA/3SA animals to systemic activation oftion of growth factor-mediated BAD phosphorylation is
to promote the resistance of cells to proapoptotic death receptor signaling, which has been implicated in a
wide variety of infectious and noninfectious pathologies,stimuli.
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BAD3SA/3SA animals died, with an average time to death
of 121 54 min (n 11). In contrast, only 54% of BAD/
mice died after anti-Fas antibody injection, with an aver-
age time to death of 495  23 min (Figure 5A; n  10).
These findings reveal that dephosphorylation of BAD
sensitizes animals to the potentially lethal effects of sys-
temic activation of the Fas receptor pathway, and sug-
gest that BAD phosphorylation plays a role in the whole
organism by attenuating the apoptotic effects of death
receptor signaling.
We next asked whether BAD phosphorylation also
regulates the response of animals to DNA damage, with
which mammalian organisms must contend throughout
the course of a normal lifespan. Exposure of animals
to 	 irradiation induces organismal death, and growth
factors have been shown to block 	 irradiation-induced
death, although the mechanisms by which survival fac-
tors attenuate DNA damage-mediated apoptosis were
not clear (Neta et al., 1993; Rosen et al., 1999). To deter-
mine whether BAD phosphorylation regulates organis-
mal responses to genotoxic damage, we subjected both
BAD/ and BAD 3SA/3SA mice to 8.5 Gray of whole-body 	
irradiation, and assessed mouse survival over a 3-week
period. As shown in Figure 5B, BAD3SA/3SA mice are hyper-
sensitive to the effects of 	 irradiation compared to
BAD/mice. All of the BAD3SA/3SA mice (n 17) subjected
to 	 irradiation died within the experimental period, as
opposed to approximately 35% of control mice (n 
11). We conclude that the maintenance of BAD in a
phosphorylated and inactivated state renders mice less
sensitive to the potentially deleterious effects of DNA
damage.
BAD Phosphorylation Alters the Threshold
Figure 5. BAD Phosphorylation Is Required for Normal In Vivo Re- for Mitochondrial Cytochrome C Release
sponses to Death Receptor Signaling and to 	 Irradiation The observation that BAD phosphorylation attenuates
(A) Five- to seven-week-old mice were injected into the retroorbital organismal and cellular responses to death cues led us
plexus with 0.2 g/g anti-Fas antibody brought up to 50 l total to investigate the mechanism by which dephosphoryla-
volume in PBS, and time of death was assessed after injection.
tion of BAD sensitizes cells to proapoptotic signaling.Retroorbital injection with PBS alone did not induce any mortality.
As the molecular basis for Fas receptor-dependent apo-(B) Adult female mice were subjected to 8.5 Gy of 	 irradiation,
ptosis is well characterized in many cell types (Li andand mortality was assessed over the time period indicated. Similar
results were obtained with male mice, although the kinetics of death Yuan, 1999), we investigated the mechanism by which
were accelerated (data not shown). BAD dephosphorylation sensitizes cells to the effects
of Fas signaling. In both MEFs and mature thymocytes,
ligation of the Fas receptor induces the nucleation of a
receptor-proximal multiprotein complex that includesincluding fulminant hepatitis, vascular leak syndrome,
and encephalomyelitis (Licon Luna et al., 2002; Rafi et the death protease caspase-8. In thymocytes and other
type I cells, cell death is induced by a caspase-8-depen-al., 1998; Yin et al., 1999). Injection of mice with anti-
Fas antibodies that activate Fas signaling induces dent caspase cascade that does not require mitochon-
drial cytochrome c release (Scaffidi et al., 1998). In MEFsmultiorgan damage and causes rapid death due to hepa-
tocellular apoptosis (Yin et al., 1999). Western blot analy- and other type II cells, cell death is a consequence of
caspase-8-mediated cleavage of the BH3-only proteinsis revealed that BAD was both expressed and phos-
phorylated in liver hepatocytes, suggesting that BAD BID. BID cleavage generates active tBID, which translo-
cates to the mitochondria, induces cytochrome c re-phosphorylation plays a role in normal tissue homeosta-
sis (data not shown). To test the responses of BAD 3SA/3SA lease, and causes apoptosis (Li et al., 1998; Luo et al.,
1998). As shown in Figure 6A, cultured BAD/ andmice to in vivo activation of Fas signaling, we first de-
fined an intravenous dose of anti-Fas antibodies (0.2 BAD3SA/3SA thymocytes did not exhibit any differences in
the level of death induced by treatment of these cellsg/g) at which 50% of 5- to 7-week-old wild-type mice
died within 24 hr. We then compared the kinetics and with anti-Fas antibodies. This result suggests that BAD
dephosphorylation does not alter the activation of deathextent of animal death after anti-Fas antibody injection
in the BAD/ and BAD3SA/3SA mice. As shown in Figure receptors, or death receptor-induced caspase activity.
Consistent with this interpretation, Western blot analysis5A, BAD3SA/3SA mice were hypersensitive to injection with
activating anti-Fas antibodies, as 90% of injected demonstrated that death receptor activation induced
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Figure 6. Survival Factor-Dependent BAD Phosphorylation Raises the Mitochondrial Threshold for Cytochrome C Release
(A) Thymocytes were isolated, cultured in the indicated media, treated with either no stimulus or 200 ng/ml anti-Fas antibody and 1 g/ml
cyclohexamide, and the levels of apoptosis assessed by trypan blue exclusion after 6 hr of culture (n  3). Treatment of thymocytes with
either 5 Gy of 	 irradiation or etoposide induced increased cell death in BAD3SA/3SA thymocytes (hatched bars) relative to BAD/ thymocytes
(white bars) when cultured in serum (data not shown)
(B) Western blot of RIPA lysates of MEFs with either -BID antibody (top panel), or -cleaved PARP antibody (bottom panel) after the indicated
treatment. In the top panel only, cells were preincubated with the caspase-9 inhibitor LEHD-CHO to prevent caspase-3-mediated activation
of caspase-8. In both panels, protein levels were normalized before loading by BCA assay. Loss of immunoreactivity with the full-length BID
antibody reflects BID cleavage.
(C) Cytochrome c release from isolated liver mitochondria. Mitochondria were isolated from liver by differential centrifugation, purified by
Percoll gradient, and then incubated for the time indicated with either vehicle or 150 M recombinant tBID (see Experimental Procedures).
the cleavage of BID in BAD/ MEFs, but that BID was apoptotic responses to Fas signaling in type I cells sug-
gests that BAD promotes apoptosis by acting at thecleaved to an equal extent in BAD3SA/3SA MEFs in the
absence or presence of death receptor activation (Fig- mitochondria, consistent with previous data indicating
that BAD interacts with antiapoptotic BCL-2 familyure 6B).
The finding that BAD dephosphorylation does not alter members localized at the mitochondria. In addition,
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DNA-damaging agents and death receptor signaling in and histological analysis of tissues in the BAD3SA/3SA
mouse revealed little evidence of excessive cell death.type II cells induce apoptosis in a manner that is depen-
BAD3SA/3SA MEFs did not exhibit defects in proliferation,dent upon an increase in the activity of proapoptotic
and did not undergo spontaneous apoptosis at a higherBCL-2 family members that act at the mitochondria (Pu-
rate than BAD/ MEFs (Figure 4 and data not shown).thalakath and Strasser, 2002). These observations led
The cell volume of BAD3SA/3SA thymocytes was not alteredus to hypothesize that dephosphorylated BAD might
compared to wild-type cells, suggesting that the abilitysensitize cells to apoptotic stimuli by lowering the mito-
of BAD3SA/3SA cells to maintain cell size, an indirect mea-chondrial threshold at which proapoptotic BCL-2 family
sure of cellular health, is not impaired (data not shown).members trigger cytochrome c release. To test this hy-
In addition, BAD dephosphorylation did not sensitizepothesis, we assessed the level of tBID-induced cyto-
cells to apoptosis that occurs independently of mito-chrome c release from isolated mitochondria from
chondrial dysfunction, as mature thymocytes culturedBAD/ and BAD3SA/3SA livers. Purified BAD3SA/3SA mito-
from BAD3SA/3SA mice did not exhibit enhanced sensitivitychondria exhibited increased cytochrome c release rela-
to death receptor signaling when compared to wild-tive to BAD/ mitochondria (27.7  5.6 percent release
type thymocytes. In contrast, BAD dephosphorylationversus 13.4  2.7 percent release at 30 min), indicating
sensitized MEFs and animals to apoptosis induced bythat BAD dephosphorylation sensitizes mitochondria to
death receptor signaling and DNA-damaging agents,the activity of tBID, a downstream effector of Fas signal-
which cause mitochondrial damage through the activa-ing (Figure 6C). As assessed by Western blot, BAD 3SA/3SA
tion of proapoptotic BCL-2 family members (Figure 4).MEFs also exhibited biochemical characteristics consis-
Taken together, these findings suggest that BAD phos-tent with excessive release of cytochrome c after death
phorylation and dephosphorylation specifically regulatereceptor signaling, such as increased caspase-3-
the responses of cells to apoptotic stimuli that inducedependent cleavage of the poly-ADP-ribose polymerase
mitochondrial dysfunction.relative to that observed in BAD/ MEFs (Figure 6B).
The mechanism by which dephosphorylated BAD co-These findings indicate that a function of growth factor-
operates with other proapoptotic BCL-2 family membersdependent BAD phosphorylation in both animals and
such as tBID to stimulate mitochondrial dysequilibriumcultured cells is to raise the threshold at which mito-
and cytochrome c release is not yet clear. The ability ofchondria release cytochrome c in response to apoptotic
dephosphorylated BAD to sensitize mitochondria to thestimuli.
proapoptotic effects of tBID may reflect the ability of
dephosphorylated BAD to lower the effective concentra-Discussion
tion of prosurvival BCL-2 family members such that less
tBID is needed to induce BAK and BAX activation andThe findings in this manuscript define a role for growth
cell death (Wei et al., 2001). If such a mechanism oper-factor-dependent BAD phosphorylation in increasing
ates, one would predict that when prosurvival BCL-2the resistance of cells to apoptotic stimuli. We find that
family members are less abundant, cells would be moregrowth factors are unable to block effectively apoptosis
sensitive to the effects of apoptotic stimuli. This predic-
induced by either the cell-intrinsic or cell-extrinsic death
tion is supported by the finding that mice in which pro-
pathways in BAD3SA/3SA cells, consistent with a role for
survival BCL-2 family members have been deleted are
endogenous BAD phosphorylation in mediating survival
hypersensitive to the effects of both cell-intrinsic and
signals. This defect is also reflected at the organismal cell-extrinsic apoptotic signaling (Ma et al., 1995; Veis
level, as BAD3SA/3SA animals are more susceptible than et al., 1993).
BAD/ animals to the effects of Fas receptor ligation The low number of prolymphocytes observed in
and ionizing radiation. Finally, growth factor-dependent BAD3SA/3SA mice may be caused by the inactivation of
BAD phosphorylation increases the ability of mitochon- BCL-2 and related proteins by dephosphorylated BAD.
dria to withstand proapoptotic signals, as mitochondria The loss of pro-T and pro-B cells in the BAD3SA/3SA mice
in which BAD is constitutively dephosphorylated release may also be a consequence of the DNA rearrangements
more cytochrome c in response to tBID than do wild- that occur during the pro-T and pro-B stages of lympho-
type mitochondria. As growth factors induce endoge- cyte development. Evidence suggests that physiological
nous BAD phosphorylation in a large number of cell DNA rearrangements can induce the DNA damage re-
types, these results suggest that BAD phosphorylation sponse (Danska and Guidos, 1997). Prolymphocytes
plays a general role in raising the threshold at which that are undergoing DNA rearrangement may therefore
mitochondria release cytochrome c and induce apopto- be particularly vulnerable to death when BAD is dephos-
sis in response to death signals. We conclude that BAD phorylated, as active BAD sensitizes cells to the proapo-
phosphorylation serves as a mechanism by which cells ptotic effects of the DNA damage response. Such a
assess whether growth factors are present or absent mechanism may explain the finding that BAD3SA/3SA mice
during a proapoptotic stimulus, to allow cells to respond exhibit a specific defect in prolymphocytes, rather than
appropriately when faced with conflicting extracellular in most other cells, in which DNA rearrangements are
survival and death cues. believed not to occur.
Several lines of evidence suggest that BAD dephos- Additional defects whose cellular basis is not yet un-
phorylation specifically lowers the mitochondrial thresh- derstood were also noted in the BAD3SA/3SA mice, includ-
old for cell death, but does not nonspecifically cause ing low body weight, uterine atrophy, and ovarian dys-
cells to be generally unhealthy. BAD3SA/3SA mice appeared function (data not shown). However, the largely normal
as healthy as wild-type counterparts when housed in development of BAD3SA/3SA mice was somewhat surpris-
ing and suggests that survival factors block cell deathsterile conditions, BAD3SA/3SA mice survived to adulthood,
Defective Survival Signaling in BAD Knockin Mouse
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Experimental Proceduresduring development through mechanisms in addition
to BAD phosphorylation. One potential target that may
Materialsmediate the ability of growth factors to block apoptosis
All reagents unless otherwise noted were obtained from Sigma
is the proapoptotic transcription factor FOXO3a. While chemicals, and the various BAD, CREB, PAK, and FOXO3a antibod-
BAD dephosphorylation alone is not generally sufficient ies were generated and utilized as described previously (Brunet et
al., 1999; Datta et al., 1997, 2000; Shamah et al., 2001). The pAkt,to induce cell death during development, our findings
p90RSK, pp90RSK, and cleaved PARP antibodies (CST), the BID, BIM,support a model in which BAD cooperates with FOXO3a
and BAK antibodies (R&D Systems), the 
-galactosidase antibodyto regulate developmental apoptosis. The mechanism
(5, 3), the Akt and BCL-XL antibodies (UBI), CD8-FITC, CD4-PE,that underlies this cooperativity has not yet been charac-
CD25-PE, CD3-FITC, CD4-FITC, CD19-biotin, B220-PE, and CD43-
terized, but the ability of FOXO3a to activate genes such FITC (BD Pharmingen), and the RED670 secondary reagent (GIBCO)
as Fas ligand and BIM, which activate the cell-extrinsic were all used according to manufacturers’ protocols. IGF-1 (Roche)
and cell-intrinsic death pathways, suggests that death was used at 50 ng/ml, PDGF (UBI) was used at 20 ng/ml, and IL-7
(R&D Systems) was used at 10 ng/ml. Jo2 -Fas antibodies (BDsignals from FOXO3a and BAD are functionally inte-
Pharmingen) were used at 200 ng/ml and TNF (UBI) was used atgrated at the mitochondria. The synergy between BAD
1 g/ml unless otherwise noted.and FOXO3a also suggests that growth factors do not
block cell death by the phosphorylation and inactivation
of a single molecule in mammals, but rather through the Cloning and Targeting of BAD Genomic Locus
coordinated inactivation of multiple apoptotic regulators The BAD cDNA was used to probe a  phage 129/SvJ mouse geno-
mic DNA library, and a 12 kB XbaI fragment from a positive clonethat interact at the mitochondria to promote cell death.
was subcloned into pBR322 to generate pBR322gBAD. Details ofBoth FOXO3a and BAD have been proposed to be
the isolation and characterization of this fragment will be publishedregulated by PI3K and downstream kinases such as Akt
elsewhere (A.M.R. and S.J.K., submitted). Serine-to-alanine muta-that have been implicated in promoting cell survival.
tions of Ser-112, Ser-136, and Ser-155 with silent RFLPs (encoding
There is evidence that in some cell types, Akt directly an XbaI site linked to Ser-112A, an SmaI site linked to Ser-136A,
phosphorylates and inactivates BAD (reviewed in Datta and an EcoRI site linked to Ser-155A) were introduced into BAD
et al., 1999). However, it remains to be determined exon 3 by QuickChange using pBR322gBAD as a template. A 900
bp SexA1/RsrII fragment containing mutations only at the three siteswhether Akt activity and BAD phosphorylation are func-
was swapped into a new pBR322gBAD construct. An FRT-PGK-tionally linked in vivo. BAD3SA/3SA mice phenocopy many
NEO-FRT cassette was cloned into an NsiI site 1.4 kB distal to theof the defects observed in mice with homozygous muta-
BAD 3 UTR, and a diphtheria toxin-negative selection cassette was
tions in the Akt1 gene, including hypersensitivity to Fas introduced into the genomic BAD/pBR322 junction at the 5 end of
and TNF signaling in MEFs, low body weight, increased the BAD locus. This vector was electroporated into 129 J1 ES cells,
apoptosis of thymocytes, and hypersensitivity to 	 irra- and standard characterization, injection (into C57B6 blastocysts),
and molecular biology techniques were used to identify homologousdiation (Figures 4 and 5, and data not shown; Chen et
recombinants. The SexA1/RsrII fragment was reisolated from miceal., 2001; Cho et al., 2001). Given the similarities between
positive for the marker RFLPs, cloned into a TOPO vector, andthe Akt1/ and the BAD3SA/3SA phenotypes, we speculate
sequenced to verify that BAD3SA/ mice indeed carried the appro-that under some circumstances, Akt1 may inhibit mito-
priate mutations.
chondria-mediated death by inactivating BAD.
In addition to its proposed role in cell survival during
development, the PI3K/Akt pathway has been impli- Cell Culture and Biochemistry
Thymocytes were isolated by mechanical dissociation, and deadcated in tumorigenesis. Increased activity of the PI3K/
cells were removed with the MACS dead cell removal kit (MiltenyiAkt cascade has been implicated in the ability of tumors
Biotechnology) and cultured in RPMI 1640-supplemented penicillin/to tolerate genomic damage, and in the resistance of
streptomycin, glutamine, 10 mM HEPES (pH 7.2), and 50 M
tumors to radio- or chemotherapy (Nicholson and An-

-mercaptoethanol. When thymocytes were cultured in full media,
derson, 2002). The findings we report here and the re- this mixture was supplemented with 10% FBS (Hyclone). MEFs were
cent analysis of BAD/ mice, which both exhibit aber- isolated from E13.5 embryos from heterozygote crosses, and sub-
jected to posthoc genotyping as described previously (Brown et al.,rant responses to DNA damage and are cancer prone
1998). Low-passage number MEFs (passages 2–4) were cultured in(A.M.R. and S.J.K., submitted), are consistent with a role
DMEM supplemented with 15% FBS, nonessential amino acids, andfor BAD phosphorylation in oncogenesis. Since BAD
penicillin/streptomycin. In all experiments, MEFs were allowed todephosphorylation renders cells sensitive to DNA-dam-
reach confluence, and in experiments comparing starvation condi-
aging agents but does not lead to the death of most tions to those with serum or growth factors, cells were deprived of
cells under normal conditions, pharmacological agents serum for 36 hr before stimulation. MEF results were verified using
two independently isolated pairs of both wild-type and mutant MEFthat induce targeted BAD dephosphorylation have the
lines. All death receptor experiments were carried out in the pres-potential to resensitize tumors to death induced by lo-
ence of 200 ng/ml cyclohexamide. MEFs were lysed in RIPA buffercalized radio- or chemotherapy without causing exces-
(10 mM Tris [pH 7.2], 150 mM NaCl, 1% NaDOC, 1% TX-100, 0.1%sive damage to normal tissues.
SDS, 1 mM sodium vanadate), and normalized for protein content
A large number of proapoptotic substrates for sur- by BCA assay (Pierce). In indicated experiments, cells were pre-
vival-promoting kinases have been proposed, but the treated with 50 M LEHD-CHO (Calbiochem) for 2 hr before stimula-
tion with death receptor agonists and lysis. Cerebellar granule cellphysiological importance of these targets in mediating
culture and transfection were performed as previously describedthe effects of survival signals in vivo has been unclear.
(Datta et al., 1997). Apoptosis in thymocytes was determined byThe identification of the biological function of growth
trypan blue inclusion, and apoptosis in MEFs and cerebellar granulefactor-dependent inactivation of BAD fills a critical gap
neurons was detected by nuclear morphology after Hoechst 33342
in our understanding of survival signaling by demonstra- staining. Pre-B colonies were cultured in Methocult pre-B methylcel-
ting the importance of the phosphorylation-mediated lulose media (Stem Cell Technologies) according to the manufactur-
er’s protocol.inactivation of a survival kinase target.
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Cytochrome C Release Assay of apoptosis in cerebellar granule neurons by low potassium: inhibi-
tion of death by insulin-like growth factor I and cAMP. Proc. Natl.Mitochondrial isolation and the cytochrome c release assay were
performed using the Quantikine cytochrome c assay kit (R&D Sys- Acad. Sci. USA 90, 10989–10993.
tems) according to the manufacturer’s protocol. Dudek, H., Datta, S.R., Franke, T.F., Birnbaum, M.J., Yao, R., Cooper,
G.M., Segal, R.A., Kaplan, D.R., and Greenberg, M.E. (1997). Regula-
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